Faghfuri, E., Nikfar, S., Niaz, K., Faramarzi, M., & Abdollahi, M. (2018). Mitogen-activated protein kinase (MEK) inhibitors to treat melanoma alone or in combination with other kinase inhibitors. Expert Opinion on Drug Metabolism & Toxicology. https://doi.org/10.1080/17425255.2018.1432593 (Original work published 2018)